Potential teratogenic effects of ultrasound on corticogenesis: Implications for autism

Medical Hypotheses

Volumn 75, Issue 1, 2010, Pages 53-58

  Williams, E L ^a   Casanova, M F ^a  

^a University of Louisville School of Medicine   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTICONVULSIVE AGENT; BRAIN DERIVED NEUROTROPHIC FACTOR; CARBAMAZEPINE; NEUROTROPHIN; NITRIC OXIDE; THALIDOMIDE; VALPROIC ACID;

ARTICLE; AUTISM; BRAIN NERVE CELL; CELL DIFFERENTIATION; CELL MATURATION; CELL MIGRATION; CELL PROLIFERATION; DEVELOPMENTAL STAGE; FETUS ECHOGRAPHY; GANGLION; GENETIC SUSCEPTIBILITY; HUMAN; NEUROBIOLOGY; PHENOTYPE; PRENATAL DRUG EXPOSURE; STEM CELL; TERATOGENICITY; WHITE MATTER;

AUTISTIC DISORDER; FEMALE; HUMANS; PREGNANCY; RISK FACTORS; TERATOGENS; ULTRASONOGRAPHY, PRENATAL;

EID: 77953479245     PISSN: 03069877     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.mehy.2010.01.027     Document Type: Article

References (109)

1. Happé F., Frith U. The weak central coherence account: detail-focused cognitive style in autism spectrum disorders. J Autism Dev Disord 2006, 36:5-25.
2. Kogan M.D., Blumberg S.J., Schieve L.A., et al. Prevalence of parent-reported diagnosis of autism spectrum disorder among children in the US, 2007. Pediatrics 2009, 124:1395-1403.
3. Bailey A., Le Couteur A., Gottesman I., et al. Autism as a strongly genetic disorder: evidence from a British twin study. Psychol Med 1995, 25:63-77.
4. Constantino J.N., Todd R.D. Autistic traits in the general population. Arch Gen Psychiatry 2003, 60:524-530.
5. Casanova M.F. The neuropathology of autism. Brain Pathol 2007, 17:422-433.
6. Strömland K., Nordin V., Miller M., Åkerström B., Gillberg C. Autism in thalidomide embryopathy: a population study. Dev Med Child Neurol 1994, 36:351-356.
7. Ardinger H.H., Atkin J.F., Blackston R.D., et al. Verification of the fetal valproate syndrome phenotype. Am J Med Genet 1988, 29:171-185.
8. Meyer U., Yee B.K., Feldon J. The neurodevelopmental impact of prenatal infections at different times of pregnancy: the earlier the worse?. Neuroscientist 2007, 13:241-256.
9. Beaudet A.L. Autism: highly heritable but not inherited. Nat Med 2007, 13:534-536.
10. Fatemi S.H., Earle J., Kanodia R., et al. Prenatal viral infection leads to pyramidal cell atrophy and macrocephaly in adulthood: implications for genesis of autism and schizophrenia. Cell Mol Neurobiol 2002, 22:25-33.
11. Casanova M.F., Buxhoeveden D.P., Switala A.E., Roy E. Minicolumnar pathology in autism. Neurology 2002, 58:428-432.
12. Casanova M.F., Buxhoeveden D.P., Switala A.E., Roy E. Neuronal density and architecture (gray level index) in the brains of autistic patients. J Child Neurol 2002, 17:515-521.
13. Casanova M.F., Van Kooten I.A.J., Switala A.E., et al. Minicolumnar abnormalities in autism. Acta Neuropathol (Berl) 2006, 112:287-303.
14. Herbert M.R., Ziegler D.A., Makris N., et al. Localization of white matter volume increase in autism and developmental language disorder. Ann Neurol 2004, 55:530-540.
15. Casanova M.F. White matter volume increase and minicolumns in autism. Ann Neurol 2004, 56:453.
16. Rinaldi T., Silberberg G., Markram H. Hyperconnectivity of local neocortical microcircuitry induced by prenatal exposure to valproic acid. Cereb Cortex 2008, 18:763-770.
17. Casanova MF. The brain in autism. In: Haines C, Collettie SJ, editors. Autism and seizures. London: Jessica Kingsley; in press.
18. Williams E.L., Casanova M.F. Autism and dyslexia: a spectrum of cognitive styles as defined by minicolumnar morphometry. Med Hypotheses 2010, 74:59-62.
19. Cherniak C. Neural component placement. Trends Neurosci 1995, 18:522-527.
20. Bailey A., Luthert P.J., Dean A.F., et al. A clinicopathological study of autism. Brain 1998, 121:889-905.
21. Wegiel J, Kuchna I, Nowicki K, et al. The neuropathology of autism: defects of neurogenesis, neuronal migration and dysplastic changes. Acta Neuropathol (Berl); in press.
22. Nowell M.A., Hackney D.B., Muraki A.S., Coleman M. Varied MR appearance of autism: fifty-three pediatric patients having the full autistic syndrome. Magn Reson Imaging 1990, 8:811-816.
23. Vaccarino F.M., Schwartz M.L., Hartigan D., Leckman J.F. Basic fibroblast growth factor increases the number of excitatory neurons containing glutamate in the cerebral cortex. Cereb Cortex 1995, 5:64-78.
24. Vaccarino F.M., Schwartz M.L., Raballo R., et al. Changes in cerebral cortex size are governed by fibroblast growth factor during embryogenesis. Nat Neurosci 1999, 2:246-253.
25. Cheng A., Wang S., Cai J., Rao M.S., Mattson M.P. Nitric oxide acts in a positive feedback loop with BDNF to regulate neural progenitor cell proliferation and differentiation in the mammalian brain. Dev Biol 2003, 258:319-333.
26. Tsai S.-J. Is autism caused by early hyperactivity of brain-derived neurotrophic factor?. Med Hypotheses 2005, 65:79-82.
27. Nelson K.B., Grether J.K., Croen L.A., et al. Neuropeptides and neurotrophins in neonatal blood of children with autism or mental retardation. Ann Neurol 2001, 49:597-606.
28. Miyazaki K., Narita N., Sakuta R., et al. Serum neurotrophin concentrations in autism and mental retardation: a pilot study. Brain Dev 2004, 26:292-295.
29. Noctor S.C., Martínez-Cerdeño V., Ivic L., Kriegstein A.R. Cortical neurons arise in symmetric and asymmetric division zones and migrate through specific phases. Nat Neurosci 2004, 7:136-144.
30. Nadarajah B. Radial glia and somal translocation of radial neurons in the developing cerebral cortex. Glia 2003, 43:33-36.
31. Rakic P., Kornack D. Neocortical expansion and elaboration during primate evolution: a view from neuroembryology. Evolutionary anatomy of the primate cerebral cortex 2001, 30-56. Cambridge University Press, Cambridge. D. Falk, K.R. Gibson (Eds.).
32. Nau H., Kuhnz W., Egger H.J., Rating D., Helge H. Anticonvulsants during pregnancy and lactation: transplacental, maternal and neonatal pharmacokinetics. Clin Pharmacokinet 1982, 7:508-543.
33. Holmes L.B., Harvey E.A., Coull B.A., et al. The teratogenicity of anticonvulsant drugs. N Engl J Med 2001, 344:1132-1138.
34. Williams G., King J., Cunningham M., Stephan M., Kerr B., Hersh J.H. Fetal valproate syndrome and autism: additional evidence of an association. Dev Med Child Neurol 2001, 43:202-206.
35. Moore S.J., Turnpenny P.D., Quinn A., et al. A clinical study of 57 children with fetal anticonvulsant syndromes. J Med Genet 2000, 37:489-497.
36. Rasalam A.D., Hailey H., Williams J.H.G., et al. Characteristics of fetal anticonvulsant syndrome associated autistic disorder. Dev Med Child Neurol 2005, 47:551-555.
37. Markram H., Rinaldi T., Markram K. The intense world syndrome-an alternative hypothesis for autism. Frontiers Neurosci 2007, 1:77-96.
38. Buka S.L., Tsuang M.T., Torrey E.F., Klebanoff M.A., Bernstein D., Yolken R.H. Maternal infections and subsequent psychosis among offspring. Arch Gen Psychiatry 2001, 58:1032-1037.
39. Ahlfors K., Ivarsson S.-A., Harris S. Report on a long-term study of maternal and congenital cytomegalovirus infection in Sweden: review of prospective studies available in the literature. Scand J Infect Dis 1999, 31:443-457.
40. Brown A.S. Prenatal infection as a risk factor for schizophrenia. Schizophr Bull 2006, 32:200-202.
41. Brown A.S., Cohen P., Harkavy-Friedman J., et al. Prenatal rubella, premorbid abnormalities, and adult schizophrenia. Biol Psychiatry 2001, 49:473-486.
42. Chess S., Fernandez P., Korn S. Behavioral consequences of congenital rubella. J Pediatr 1978, 93:699-703.
43. Forrest J.M., Menser M.A., Burgess J.A. High frequency of diabetes mellitus in young adults with congenital rubella. Lancet 1971, 298:332-334.
44. Menser M.A., Dods L., Harley J.D. A twenty-five-year follow-up of congenital rubella. Lancet 1967, 7530:1347-1350.
45. Chess S. Autism in children with congenital rubella. J Autism Child Schizophr 1971, 1:33-47.
46. Dyson M., Brookes M. Stimulation of bone repair by ultrasound. Ultrasound Med Biol 1983, (Suppl. 2):61-66.
47. Pilla A.A., Mont M.A., Nasser P.R., et al. Non-invasive low-intensity pulsed ultrasound accelerates bone healing in the rabbit. J Orthop Trauma 1990, 4:246-253.
48. Wang S.-J., Lewallen D.G., Bolander M.E., Chao E.Y.S., Ilstrup D.M., Greenleaf J.F. Low intensity ultrasound treatment increases strength in a rat femoral fracture model. J Orthop Res 1994, 12:40-47.
49. Cui J.H., Park K., Park S.R., Min B.-H. Effects of low-intensity ultrasound on chondrogenic differentiation of mesenchymal stem cells embedded in polyglycolic acid: an in vivo study. Tissue Eng 2006, 12:75-82.
50. Yang R.-S., Lin W.-L., Chen Y.-Z., et al. Regulation by ultrasound treatment on the integrin expression and differentiation of osteoblasts. Bone 2005, 36:276-283.
51. 2 production by human osteoblasts. Bone 2002, 31:236-241.
52. Moncada S., Higgs E.A., Hodson H.F., et al. The l-arginine-nitric oxide pathway. J Cardiovasc Pharmacol 1991, 17:vii.
53. Suchkova V.N., Baggs R.B., Sahni S.K., Francis C.W. Ultrasound improves tissue perfusion in ischemic tissue through a nitric oxide dependent mechanism. Thromb Haemost 2002, 88:865-870.
54. Altland O.D., Dalecki D., Suchkova V.N., Francis C.W. Low-intensity ultrasound increases endothelial cell nitric oxide synthase activity and nitric oxide synthesis. J Thromb Haemost 2004, 2:637-643.
55. Chen J., Tu Y., Moon C., Matarazzo V., Palmer A.M., Ronnett G.V. The localization of neuronal nitric oxide synthase may influence its role in neuronal precursor proliferation and synaptic maintenance. Dev Biol 2004, 269:165-182.
56. Thippeswamy T., Morris R. Nerve growth factor inhibits the expression of nitric oxide synthase in neurones in dissociated cultures of rat dorsal root ganglia. Neurosci Lett 1997, 230:9-12.
57. Thippeswamy T., Jain R.K., Mumtaz N., Morris R. Inhibition of neuronal nitric oxide synthase results in neurodegenerative changes in the axotomised dorsal root ganglion neurons: evidence for a neuroprotective role of nitric oxide in vivo. Neurosci Res 2001, 40:37-44.
58. Gibbs S.M. Regulation of neuronal proliferation and differentiation by nitric oxide. Mol Neurobiol 2003, 27:107-120.
59. Villalobo A. Enhanced cell proliferation induced by nitric oxide. Dyn Cell Biol 2007, 1:60-64.
60. Traister A., Abashidze S., Gold V., et al. Evidence that nitric oxide regulates cell-cycle progression in the developing chick neuroepithelium. Dev Dyn 2002, 225:271-276.
61. Sweeten T.L., Posey D.J., Shankar S., McDougle C.J. High nitric oxide production in autistic disorder: a possible role for interferon-γ. Biol Psychiatry 2004, 55:434-437.
62. Zoroĝlu S.S., Yürekli M., Meram I., et al. Pathophysiological role of nitric oxide and adrenomedullin in autism. Cell Biochem Funct 2003, 21:55-60.
63. Söĝüt S., Zoroĝlu S.S., Özyurt H., et al. Changes in nitric oxide levels and antioxidant enzyme activities may have a role in the pathophysiological mechanisms involved in autism. Clin Chim Acta 2003, 331:111-117.
64. Reher P., Doan N., Bradnock B., Meghji S., Harris M. Effect of ultrasound on the production of IL-8, basic FGF and VEGF. Cytokine 1999, 11:416-423.
65. Doan N., Reher P., Meghji S., Harris M. In vitro effects of therapeutic ultrasound on cell proliferation, protein synthesis, and cytokine production by human fibroblasts, osteoblasts, and monocytes. J Oral Maxillofac Surg 1999, 57:409-419.
66. Bonthius D.J., Karacay B., Dai D., Pantazis N.J. FGF-2, NGF and IGF-1, but not BDNF, utilize a nitric oxide pathway to signal neurotrophic and neuroprotective effects against alcohol toxicity in cerebellar granule cell cultures. Brain Res Dev Brain Res 2003, 140:15-28.
67. Palmer T.D., Ray J., Gage F.H. FGF-2-responsive neuronal progenitors reside in proliferative and quiescent regions of the adult rodent brain. Mol Cell Neurosci 1995, 6:474-486.
68. Okabe S., Forsberg-Nilsson K., Spiro A.C., Segal M., McKay R.D.G. Development of neuronal precursor cells and functional postmitotic neurons from embryonic stem cells in vitro. Mech Dev 1996, 59:89-102.
69. Vaccarino F.M., Grigorenko E.L., Müller Smith K., Stevens H.E. Regulation of cerebral cortical size and neuron number by fibroblast growth factors: implications for autism. J Autism Dev Disord 2009, 39:511-520.
70. Redcay E., Courchesne E. When is the brain enlarged in autism? A meta-analysis of all brain size reports. Biol Psychiatry 2005, 58:1-9.
71. Fidler D.J., Bailey J.N., Smalley S.L. Macrocephaly in autism and other pervasive developmental disorders. Dev Med Child Neurol 2000, 42:737-740.
72. McCaffery P., Deutsch C.K. Macrocephaly and the control of brain growth in autistic disorders. Prog Neurobiol 2005, 77:38-56.
73. Trikalinos T.A., Karvouni A., Zintzaras E., et al. A heterogeneity-based genome search meta-analysis for autism-spectrum disorders. Mol Psychiatry 2006, 11:29-36.
74. Fukumitsu H., Ohtsuka M., Murai R., Nakamura H., Itoh K., Furukawa S. Brain-derived neurotrophic factor participates in determination of neuronal laminar fate in the developing mouse cerebral cortex. J Neurosci 2006, 26:13218-13230.
75. Gates M.A., Tai C.C., Macklis J.D. Neocortical neurons lacking the protein-tyrosine kinase B receptor display abnormal differentiation and process elongation in vitro and in vivo. Neuroscience 2000, 98:437-447.
76. Ang E.S.B.C., Gluncic V., Duque A., Schafer M.E., Rakic P. Prenatal exposure to ultrasound waves impacts neuronal migration in mice. Proc Natl Acad Sci USA 2006, 103:12903-12910.
77. Ebisawa K., Hata K.-I., Okada K., et al. Ultrasound enhances transforming growth factor β-mediated chondrocyte differentiation of human mesenchymal stem cells. Tissue Eng 2004, 10:921-929.
78. Hande M.P., Devi P.U., Karanth K.S. Effect of prenatal ultrasound exposure on adult behavior in mice. Neurotoxicol Teratol 1993, 15:433-438.
79. Hande M.P., Devi P.U. Teratogenic effects of repeated exposures to X-rays and/or ultrasound in mice. Neurotoxicol Teratol 1995, 17:179-188.
80. Suresh R., Devi P.U., Ovchinnikov N., McRae A. Long-term effects of diagnostic ultrasound during fetal period on postnatal development and adult behavior of mouse. Life Sci 2002, 71:339-350.
81. Suresh R., Rao T.R., Davis E.M., Ovchinnikov N., Mc Rae A. Effect of diagnostic ultrasound during the fetal period on learning and memory in mice. Anat Anz 2008, 190:37-45.
82. Kieler H., Cnattingius S., Haglund B., Palmgren J., Axelsson O. Sinistrality-a side-effect of prenatal sonography: a comparative study of young men. Epidemiology 2001, 12:618-623.
83. Kieler H., Axelsson O., Haglund B., Nilsson S., Salvesen K.Å. Routine ultrasound screening in pregnancy and the children's subsequent handedness. Early Hum Dev 1998, 50:233-245.
84. Salvesen K.Å., Eik-Nes S.H., Hugdahl K., Bakketeig L.S. Routine ultrasonography in utero and subsequent handedness and neurological development. BMJ 1993, 307:159-164.
85. Campbell J.D., Elford R.W., Brant R.F. Case-control study of prenatal ultrasonography exposure in children with delayed speech. Can Med Assoc J 1993, 149:1435-1440.
86. Evans S., Newnham J., MacDonald W., Hall C. Characterisation of the possible effect on birthweight following frequent prenatal ultrasound examinations. Early Hum Dev 1996, 45:203-214.
87. Newnham J.P., Evans S.F., Michael C.A., Stanley F.J., Landau L.I. Effects of frequent ultrasound during pregnancy: a randomised controlled trial. Lancet 1993, 342:887-891.
88. Fatemi M., Ogburn P.L., Greenleaf J.F. Fetal stimulation by pulsed diagnostic ultrasound. J Ultrasound Med 2001, 20:883-889.
89. Grether J.K., Li S.X., Yoshida C.K., Croen L.A. Antenatal ultrasound and risk of autism spectrum disorders. J Autism Dev Disord 2010, 40:238-245.
90. Miller M.W., Brayman A.A., Abramowicz J.S. Obstetric ultrasonography: a biophysical consideration of patient safety-the " rules" have changed. Am J Obstet Gynecol 1998, 179:241-254.
91. O'Brien W.D. Ultrasound-biophysics mechanisms. Prog Biophys Mol Biol 2007, 93:212-255.
92. ARDMS. 2009 information and examination booklet. Rockville: American Registry for Diagnostic Medical Sonography; 2009.
93. Sheiner E., Shoham-Vardi I., Abramowicz J.S. What do clinical users know regarding safety of ultrasound during pregnancy?. J Ultrasound Med 2007, 26:319-325.
94. Rados C. FDA cautions against ultrasound 'keepsake' images. FDA Consum 2004, 38:12-16.
95. Alberta CPG Working Group for Prenatal Ultrasound. Guideline for the use of prenatal ultrasound: first trimester, Alberta clinical practice guidelines. Edmonton: Alberta Medical Association; 1998.
96. American College of Radiology. Practice guideline for the performance of obstetrical ultrasound, ACR practice guidelines. Resolution 25 (2007).
97. MacMahon B. Prenatal X-ray exposure and childhood cancer. J Natl Cancer Inst 1962, 28:1173-1191.
98. Office of Inspector General. Medicare part B billing for ultrasound. Washington, DC: Department of Health and Human Services; 2009.
99. Senate Community Affairs References Committee. Rocking the cradle: a report into childbirth procedures. Canberra: Senate Printing Unit; 1999.
100. Rodgers C. Questions about prenatal ultrasound and the alarming increase in autism. Midwifery Today Int Midwife 2006, 80. 16-19, 66-67.
101. Jørgensen F.S. Epidemiological studies of obstetric ultrasound examinations in Denmark 1989-1990 versus 1994-1995. Acta Obstet Gynecol Scand 1999, 78:305-309.
102. Mazur-Kolecka B., Cohen I.L., Jenkins E.C., et al. Sera from children with autism alter proliferation of human neuronal progenitor cells exposed to oxidation. Neurotox Res 2009, 16:87-95.
103. Liu J., Nyholt D.R., Magnussen P., et al. A genomewide screen for autism susceptibility loci. Am J Hum Genet 2001, 69:327-340.
104. Beversdorf D.Q., Manning S.E., Hillier A., et al. Timing of prenatal stressors and autism. J Autism Dev Disord 2005, 35:471-478.
105. Van den Bergh B.R.H., Mulder E.J.H., Mennes M., Glover V. Antenatal maternal anxiety and stress and the neurobehavioural development of the fetus and child: links and possible mechanisms. Neurosci Biobehav Rev 2005, 29:237-258.
106. Maeda H., Akaike T. Nitric oxide and oxygen radicals in infection, inflammation, and cancer. Biochemistry (Mosc) 1998, 63:854-865.
107. Shaamash A.H., Elsnosy E.D., Makhlouf A.M., Zakhari M.M., Ibrahim O.A., El-dien H.M. Maternal and fetal serum nitric oxide (NO) concentrations in normal pregnancy, pre-eclampsia and eclampsia. Int J Gynaecol Obstet 2000, 68:207-214.
108. Pandhi P., Balakrishnan S. Cognitive dysfunction induced by phenytoin and valproate in rats: effect of nitric oxide. Indian J Physiol Pharmacol 1999, 43:378-382.
109. Shimazawa R., Sano H., Tanatani A., Miyachi H., Hashimoto Y. Thalidomide as a nitric oxide synthase inhibitor and its structural development. Chem Pharm Bull (Tokyo) 2004, 52:498-499.